Business · 03/01/2002
US FDA to Host Joint Meeting of Advisory Committees on Transmissible Spongiform Encephalopathies and Blood Products
The US FDA will convene a joint meeting of the Transmissible Spongiform Encephalopathies Advisory Committee and the Blood Products Advisory Committee to discuss recent developments and schedule for the upcoming year
Original source language: Federal Register — Food and Drug AdministrationOpen original release →